SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$19.00
-0.04 (-0.21%)
Open$19.60
Previous Close$19.04
Day High$20.37
Day Low$18.93
52W High$25.59
52W Low$8.59
Volume—
Avg Volume2.05M
Market Cap1.68B
P/E Ratio—
EPS$-2.80
SectorBiotechnology
Analyst Ratings
Strong Buy
20 analysts
Price Target
+28.9% upside
Current
$19.00
$19.00
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 181.46M | 42.66M | 332.47M |
| Net Income | -300,501,751 | -516,701,989 | -96,723,913 |
| Profit Margin | -165.6% | -1,278.8% | -29.1% |
| EBITDA | -287,505,454 | -581,608,963 | -125,567,751 |
| Free Cash Flow | — | — | -63,645,585 |
| Rev Growth | — | -44.7% | -3.0% |
| Debt/Equity | 5.32 | 1.19 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.93 | +0.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $352.99 | +1.72% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.88 | +0.66% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $478.81 | +2.22% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $626.31 | +1.34% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $300.33 | +4.22% | 64.3 | 37.13B |